A Brand New Nasdaq AI Stock Just Hit the Market

Why This New Nasdaq AI Pick Is Turning Heads Early
 ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  

You are receiving this email because you are subscribed to Morning Watchlist from Behind the Markets. If you no longer wish to receive these partner emails, please unsubscribe here. A Brand New Nasdaq Listing Is Being Quietly Ignored Something unusual just happened on Nasdaq. A company went public without the usual hype cycle, without a wave of analyst notes, and without retail traders piling in on day one. That usually means one thing. Most investors are looking the wrong way. This newly listed Nasdaq company is not selling software subscriptions or ad clicks. It is attacking one of the most broken cost structures in the economy. Retail labor. Stores that close early cap revenue. Stores that stay open late bleed cash. Staffing, security, and shrink have turned convenience retail into a math problem that no longer works. This company's solution is radical but simple. Stores that operate 24 hours a day without staff. Customers order and pay through their phone. Robotics handle fulfillment. AI manages inventory and security. The store never closes. This is not a concept or a pitch deck. Live stores are already operating in high-traffic transportation hubs, places where demand never stops and traditional retail struggles the most. Why does this matter now? Because history shows that brand new Nasdaq listings tied to a new category often make their first real move before Wall Street agrees on the narrative. By the time the research reports come out, the early opportunity is gone. This story is still in the phase where deployment matters more than valuation models. Real locations. Real customers. Repeatable infrastructure. The ticker is fresh. The category is forming. And the crowd is not here yet. Unlock the name and symbol behind this autonomous retail rollout and see why this Nasdaq listing is starting to show up on early radars. Examples that we provide of share price increases pertaining to a particular Issuer from one referenced date to another represent an arbitrarily chosen time period and are no indication whatsoever of future stock prices for that Issuer and are of no predictive value. Our stock profiles are intended to highlight certain companies for YOUR further investigation; they are NOT stock recommendations or constitute an offer or sale of the referenced securities. We would like to inform you that we have received or expect to receive compensation in connection with the purchase or sale of the securities of VenHub Global, Inc. (NASDAQ:VHUB). The compensation consists of up to $4,000 and was received/will be received from Market Jar Media. This communication should not be considered as an endorsement of the securities of adviser VenHub Global, Inc. (NASDAQ:VHUB) and we are not responsible for any errors or omissions in any information provided about the securities of VenHub Global, Inc. by Trading Whisperer or Market Jar Media. We encourage you to conduct your own due diligence and research before making any investment decisions. You should also consult with a financial advisor before making any investment decisions. This disclosure is made as of 02/10/2026. Our mailing address is: Behind the Markets, LLC 4260 NW 1st Avenue, Suite 55 Boca Raton, FL 33431 Copyright © 2024 Behind the Markets, LLC, All rights reserved. You're receiving this email as part of your subscription to Behind the Markets. For more information about our privacy practices, please review our Privacy Policy or our Legal Notices. Behind the Markets Unsubscribe invisiblelink invisiblelink

Gold is Resetting as Money - and NatGold Is Where Capital Is Moving Next

Bitcoin proved something important. ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  

You are receiving this email because you are subscribed to Morning Watchlist from Behind the Markets. If you no longer wish to receive these partner emails, please unsubscribe here. This message is from Angel Investment Research.  The window closes on February 24 - before price replaces position.                                                                                                          Bitcoin proved something important. It showed the world that digital scarcity matters – that people are willing to hold value outside fiat systems. But markets don't stand still. Today, even Bitcoin's strongest advocates like Michael Saylor are discovering a quiet truth: Bitcoin works best when the price is rising. Gold works in every environment. And right now, gold has entered a new phase. At $5,000+ an ounce, gold isn't rallying. It's resetting. It's no longer trading as a hedge. It's trading as money again. Central banks are buying. Trust in paper systems is fracturing. And most importantly: Gold is going digital. Not metaphorically. Structurally. Billions of dollars are already moving into tokenized gold – blockchain-based representations of real gold – while much of the crypto market treads water. That's not speculation. That's recognition. Which brings us to NatGold. NatGold is not another crypto token. It is the first system designed to digitally mine gold – transforming verified, in-ground gold into a digitally native monetary asset without extracting a single ounce. No bulldozers. No vaults. No storage fees. Just real gold, certified by geology and made liquid at digital speed. This is what comes after Bitcoin. And right now, there is still a brief window to position before price discovery begins. More than 118,451 NatGold Tokens have already been reserved by investors across 161 countries – representing over $355 million in pre-market demand, secured quietly before global trading begins. Because of this demand, February 24, 2026 is the final day to reserve NatGold Tokens pre-market. The first tokenization event is now just weeks away. Reserving tokens does not require payment today. It simply secures your place ahead of global trading – before access is controlled by price instead of position. This is how new monetary assets are born. Quietly at first. Then all at once. Click here to reserve your NatGold Tokens now – before price replaces position. No obligation today. Just a place at the front of a market that's about to exist. To your wealth, Brian Hicks President, Angel Investment Research P.S. Windows like this don't close loudly. They close quietly – and reappear only as prices. The window closes February 24. Reserve your NatGold Tokens now. We are issuing this disclosure in compliance with Section 17(b) of the Securities Act, which requires us to disclose any compensation received or expected to be received in cash or in kind in connection with the purchase or sale of any security. We would like to inform you that this is a paid advertisement for Nat Gold's Reg A offering and we have received or expect to receive compensation in connection with the disbursing this communication for Nat Gold. The compensation consists of up to $3,500 and was received/will be received from Investing Media Solutions. This communication should not be considered as an endorsement of the securities of Nat Gold and we are not responsible for any errors or omissions in any information provided about the securities of Nat Gold. We encourage you to conduct your own due diligence and research before making any investment decisions. You should also consult with a financial advisor before making any investment decisions. This disclosure is made as of 02/10/26. Our mailing address is: Behind the Markets, LLC 4260 NW 1st Avenue, Suite 55 Boca Raton, FL 33431 Copyright © 2024 Behind the Markets, LLC, All rights reserved. You're receiving this email as part of your subscription to Behind the Markets. For more information about our privacy practices, please review our Privacy Policy or our Legal Notices. Behind the Markets You are receiving this email because you are subscribed to Morning Watchlist from Behind the Markets. If you no longer wish to receive these partner emails, please unsubscribe here. Today's Bonus Content: Get Our TradeGPT Insight Alerts For FREE

This Might Be the Missing Piece

See how an 80% win rate is possible.  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

February 10, 2026 Let's be real for a second…  Who doesn't love the idea of a "monster win?"  That one eye-popping 300% or 400% trade that makes it feel like you finally figured everything out.  Short-term bets feel good when they work. They're a problem when they don't.  Your portfolio deserves something more dependable.  Look at the traders who actually stick around… they aren't swinging for miracles…  They're running systems. Systems built around repeatability, discipline, and staying power.  That's the thinking behind Premium Trader, and it's why it's grown into one of our most relied-on, most consistent services.  And we don't hide behind vague language either… we make a commitment.  When you join Premium Trader, you're covered by an 80% win-rate guarantee over the next 12 months.  Not "we'll see."  Not "we'll do our best."  An actual guarantee you can hold us to.  If Premium Trader doesn't deliver an 80% win rate over your 12-month term — something the service has demonstrated consistently over time — you'll receive a full refund of your subscription fee.  No pushback.  No fine print.  And this isn't a moonshot approach built on hope or hero trades.  We focus on the most durable, repeatable setups in the options market… the ones that keep you in control:   ●       Equity Credit Spreads –  Take in a credit up front… keep it as long as the stock stays in range. ●       Put Sells – Collect premium on solid names with strong support… get paid if they simply hold their ground.   That's it. Simple. Disciplined. And powerful.  Over the last 6 months, this service has generated a 104.7% total return, driven by a steady cadence of high-probability trades executed within a defined framework.  And we're confident in what comes next… confident enough to stand behind it.  Premium Trader is normally $1,495 per year, but with this discount, you can claim your first 12 months for only $75.  I'm not sure when I'll get that call from my dad to shut this offer down. But I know him pretty well, I'm not sure it'll last until tomorrow morning.  If you want to learn more on what Premium Trader will provide you with over the next 12 months AND to lock in your place, click below… Get Started Now! Sincerely,   Update your email preferences or unsubscribe here © 2026 Schaeffer's Investment Research 5151 Pfeiffer Road, Suite 450 Cincinnati, Ohio 45242, United States Terms of Service

A Masterclass in American Options, Strategic Leverage, and the Brutal Realignment of the Biotech Sector  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

February 10, 2026   |   Listen Online   |   Read Online The GLP-1 Power Play: How One Trader Turned $700k into $3.3 Million as NVO Crushed the HIMS Hype A Masterclass in American Options, Strategic Leverage, and the Brutal Realignment of the Biotech Sector The financial markets are often viewed as a chaotic sea of numbers, but for the elite derivative trader, they represent a structured grid of probability and leverage. Among the various instruments available, American Options stand out as the preferred weapon for those seeking to capitalize on short-term volatility and specific corporate catalysts. Unlike their European counterparts, American Options grant the holder the right to exercise at any point before expiration, providing a level of tactical flexibility that is essential when navigating the rapid-fire price swings of the modern biotech and pharmaceutical sectors. This flexibility becomes a force multiplier when a trader identifies a misalignment between market sentiment and an impending fundamental shift. The Mechanics of the American Option Advantage To understand how a single trade can snowball into a multi-million dollar windfall, one must first grasp the inherent power of the American-style contract. These instruments allow traders to capture "intrinsic value" the moment it manifests, rather than waiting for a fixed settlement date. In the context of high-growth equities, this means a trader can react to breaking news—such as a competitor's clinical failure or a regulatory shift—with surgical precision. Exercise Flexibility: The ability to convert options into shares at any time before expiration provides a safety net during volatile sessions. Liquidity and Volume: American options on major exchanges typically boast tighter spreads, allowing for massive "size" to be moved without alerting the entire floor. Strategic Hedging: These contracts serve as both a speculative tool and a robust hedge against existing equity positions in a portfolio. The Lithium Boom (Ad) Diu know it takes 10,000 iPhone batteries worth of lithium to make one EV battery pack? With 350M+ EVs projected to be sold globally by 2030, lithium demand is looking steep. Current recovery methods involve waiting for liquids to evaporate in ponds the size of 100 football fields. This inefficiency can't keep up with forecasted demand. But EnergyX's technology can recover up to 3X more lithium than traditional methods. Investors are taking note. EnergyX has $130M+ of investments from General Motors and others. They even earned a $5M DOE grant.  Now, they're scaling their 100,000-acre Chilean project, which has a potential target annual revenue of $1.1B. Perfect timing. You can still join 40,000+ people as an early-stage investor today. *Disclaimer: This is a paid advertisement for EnergyX's Regulation A+ Offering. Please read the offering circular at invest.energyx.com. Under Regulation A+, a company has the ability to change its share price by up to 20%, without requalifying the offering with the SEC. The $2 Million Setup: Novo Nordisk (NVO) and the 48-Hour Surge In early February 2026, the options tape began to hum with unusual activity centered around Novo Nordisk (NVO). While the broader market was focused on standard earnings reports, a specific trader saw an opening in the 2026-02-20 expiration cycle. The trade in question involved a massive purchase of 17,630 NVO $51.0 Calls, initially scooped up at a modest premium of $0.40 per contract. At the time, NVO was trading in a consolidated range, and the market appeared to be pricing in a quiet week. However, the quiet was an illusion. Over the span of just two trading days, the premium on these calls exploded. The price moved from that humble $0.40 entry point to a staggering $1.90 at the peak of the momentum. When you calculate the math on over 17,000 contracts, the realized and unrealized gains quickly eclipsed the $2.6 million mark in pure profit. This wasn't a slow grind upward; it was a violent repricing of risk that rewarded the bold and the prepared. The HIMS Connection: Predicting the Fallout The most intriguing aspect of this trade wasn't just the profit, but the timing relative to the broader "GLP-1" ecosystem. As Novo Nordisk—the primary manufacturer of Ozempic and Wegovy—saw its options premiums skyrocket, a simultaneous and brutal sell-off began to plague Hims & Hers Health (HIMS). For months, HIMS had thrived by offering compounded versions of these weight-loss drugs, but the tide was turning as supply constraints for the brand-name versions began to ease. The trader who went "long and heavy" on NVO calls seemed to anticipate a massive rotation of capital. As the market realized that the "compounding loophole" for HIMS was narrowing, investors fled the speculative secondary players and rushed back into the primary source: Novo Nordisk. This "fallout" in HIMS acted as a secondary engine for the NVO trade, as the institutional money sought the safety and dominance of the original patent holder over the telehealth distributors. Analyzing the $1.90 Exit: Timing the Top Selling is often harder than buying, especially when a position is up over 375% in less than 48 hours. The discipline required to exit the NVO $51.0 Calls at $1.90 is what separates professional "sharks" from retail "guppies." Most novice traders would have held on, hoping for the $0.40 entry to turn into $5.00, but the experienced hand knows that in the world of American options, theta (time decay) and volatility crush are constant threats. Volume Spikes: The exit was likely triggered by a massive spike in daily volume that indicated a local exhaustion point for buyers. Technical Resistance: As NVO shares approached psychological barriers, the call premiums reached a point of diminishing returns. Risk Mitigation: By clearing the position at $1.90, the trader locked in a life-changing sum, insulating themselves from the inevitable "mean reversion" that follows such parabolic moves. The "Shadow" Edge: Did They Know the Fallout was Coming? In the aftermath of such a spectacular trade, the question of "asymmetric information" always arises. Was this a lucky bet, or did the trader have a deep-rooted understanding of the regulatory landscape that was about to crater HIMS? The precision of the 17,630 contract buy-in suggests a high level of conviction that rarely comes from looking at simple chart patterns. If a trader knew that a specific supply chain update or a regulatory memo regarding compounded GLP-1s was imminent, the NVO calls would be the most efficient way to express that view. By shorting the "copycats" or simply betting on the "king," the trader utilized the American options market to front-run a fundamental shift in the pharmaceutical landscape. It is this intersection of deep sector knowledge and aggressive derivative leverage that creates the legends of the trading floor. Final Takeaway The saga of the $2 million NVO trade serves as a masterclass in modern market dynamics and the raw power of the American option. It highlights a world where the misfortunes of a company like HIMS can be the direct catalyst for a windfall in a competitor, provided one has the capital and the courage to pull the trigger. As the healthcare sector continues to be redefined by weight-loss breakthroughs, these high-stakes games will only become more frequent. For those watching the tape, the lesson is clear: follow the volume, respect the leverage, and always keep an eye on the fallout. Subscribe now Read more Disclaimer: This content is for educational purposes only and does not constitute financial advice. Options trading involves risk, and not all trades will be profitable. Always manage risk responsibly.   Update your email preferences or unsubscribe here © 2026 American Options by BZB Enterprises Inc 111 SE 1st Avenue Delray Beach, FL 33444, United States Terms of Service